Radiotherapy for overcoming immune checkpoint inhibitor resistance in esophageal squamous cell carcinoma
Immunotherapy has improved outcomes for patients with esophageal squamous cell carcinoma (ESCC), yet a substantial proportion develop resistance. The tumor microenvironment (TME) drives this resistance through four hallmarks: physical barriers formed b…